Literature DB >> 27408384

Concomitant Presence of Two Distinct Clones of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma in a Patient.

Sabina Langer1, Meenal Mehta1, Amrita Saraf1, Aastha Gupta1, Keyur Pipliya2, Atul Kakar2, Manorama Bhargava1.   

Abstract

A 74 years old male patient, presented with history of generalized weakness, fatigue, loss of appetite and breathlessness on exertion for past one and a half months. On examination, he was found to have significant pallor and generalized lymphadenopathy (cervical, axillary and inguinal). The skeletal survey showed punched out lytic lesions in skull and pelvic bones. The peripheral smear examination showed lymphocytosis with absolute lymphocyte count of 25,000/μL. The bone marrow aspirates revealed a hypercellular marrow with 74 % lymphocytes & 14 % plasma cells, suggestive of chronic lymphoplasmacytic disorder. The bone marrow biopsy had two morphologically distinct populations of lymphocytes & plasma cells. The immunohistochemical markers on bone marrow biopsy showed hat plasma cells were positive for CD138 with kappa light chain restriction. Flow cytometry showed B cell population with CD19/CD5 co expression, CD5/CD23 coexpression, were positive for CD22, CD20 and negative for FMC-7 and lambda light chain. In addition, plasma cells were also identified as CD45 negative cells and showed CD38/CD138 co-expression with variable CD19 and CD56 positivity. Serum protein electrophoresis revealed M band, serum immunofixation electrophoresis corresponded to IgA -Kappa. The final diagnosis of chronic lymphocytic leukemia with concomittant presence of plasma cell myeloma was concluded. This case imparts an important message to look for presence of coexisting entities in a single specimen and highlights the benefits of testing both plasma cell and B-cell compartments when the clinical features are not entirely consistent Flow cytometry together with protein electrophoresis can help to clinch difficult and rare dual diagnosis. These cases are rare and pose therapeutic challenge.

Entities:  

Keywords:  Chronic lymphocytic leukemia; Flow cytometry; Multiple myeloma

Year:  2015        PMID: 27408384      PMCID: PMC4925489          DOI: 10.1007/s12288-015-0512-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  21 in total

1.  Uncommon manifestations of common malignancies: case 2. Chronic lymphocytic leukemia and multiple myeloma in the same patient.

Authors:  V Lakshmi Devi; Kumar Prabhash; M Malathi; D S Madhumathi; P P Bapsy
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

2.  Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma.

Authors:  M Pantic; P Schroettner; D Pfeifer; J Rawluk; U Denz; A Schmitt-Gräff; H Veelken; R Wäsch; M Engelhardt
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

3.  Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia is comparable to flow cytometric techniques.

Authors:  Matthew T Howard; Janice Hodnefield; William G Morice
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-02

4.  Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma.

Authors:  D L Saltman; J A Ross; R E Banks; F M Ross; A M Ford; M J Mackie
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

5.  Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.

Authors:  Sridhar Srinivasan; Charles A Schiffer
Journal:  Leuk Res       Date:  2008-08-03       Impact factor: 3.156

Review 6.  [Multiple myeloma in a patient with chronic lymphocytic leukemia--case report and literature review].

Authors:  Inga Mandac Rogulj; Delfa Radić-Kristo; Vibor Milunović; Slobodanka Ostojić Kolonić; Biljana Jelić-Puskarić; Ana Planinc-Peraica
Journal:  Acta Med Croatica       Date:  2011-09

7.  Concurrent appearance of multiple myeloma with other B-cell lymphoid neoplasms. A report of two cases.

Authors:  T Kontozoglou; L F Skinnider
Journal:  Arch Pathol Lab Med       Date:  1983-05       Impact factor: 5.534

8.  Transformation of chronic lymphocytic leukemia to plasmacytoma.

Authors:  A Pines; I Ben-Bassat; G Selzer; B Ramot
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

9.  Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin.

Authors:  Hong Chang; Ashutosh Wechalekar; Linda Li; Donna Reece
Journal:  Cancer Genet Cytogenet       Date:  2004-01-01

10.  Separate clones in concomitant multiple myeloma and a second B-cell neoplasm demonstrated by molecular and immunophenotypic analysis.

Authors:  P M Novak; J C Mattson; D Crisan; J Chen; M D Poulik; D Decker
Journal:  Eur J Haematol       Date:  1995-04       Impact factor: 2.997

View more
  2 in total

1.  Coexisting multiple myeloma, lymphoma, and non-small cell lung cancer: a case report and review of the literature.

Authors:  Parth Khade; Srinivas Devarakonda
Journal:  Int Med Case Rep J       Date:  2017-11-08

2.  Microfluidic enrichment of plasma cells improves treatment of multiple myeloma.

Authors:  Yunjing Zeng; Li Gao; Xiaoqing Luo; Yan Chen; Mustafa H Kabeer; Xuelian Chen; Andres Stucky; William G Loudon; Shengwen C Li; Xi Zhang; Jiang F Zhong
Journal:  Mol Oncol       Date:  2018-05-12       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.